Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment
NCT01492127
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
64
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Cirrhosis
Interventions
BIOLOGICAL:
Blood test
Sponsor
University Hospital, Montpellier